α-aminoalkylphosphonates induced apoptosis in human tumor cell lines

Polish Journal of Chemistry

Volumn 79, Issue 3, 2005, Pages 593-602

  Drag M ^a   Sienczyk M ^a   Marcinkowska, A ^b   Drag Zalesinska M ^b   Wysocka, T ^b   Oleksyszyn, J ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

aminoalkylphosphonates; Aminopeptidase; Apoptosis; Cancer; Comet assay

Indexed keywords

1 AMINO 3 PHENYLPROPANEPHOSPHONIC ACID; BESTATIN; DIPHENYL 1 (N BENZYLOXYCARBONYLAMINO) 1 (4 AMINOPHENYL)METHANE PHOSPHONATE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; HUMAN; HUMAN CELL; INHIBITION KINETICS;

EID: 17144420568     PISSN: 01375083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aminophosphonic and Aminophosphinic acids: Chemistry and Biological Activity; Kukhar V.P., Hudson H.R., Eds.; John Wiley; New York (2000).
2. (a) Logusch E.W., Walker D.M., McDonald J.F., Leo G.C. and Franz J.E., J. Org. Chem., 53, 4069 (1988);
3. (b) Logusch E.W., Walker D.M., McDonald J.F. and Franz J.E., Biochemistry, 28, 3043 (1989);
4. (c) Cope V., Faraci S., Walsh C.T. and Griffin R.G., Biochemistry, 27, 4966 (1988);
5. (d) Lejczak B., Kafarski P. and Makowiecka E., Biochem. J., 242, 81 (1987);
6. (e) Janas K., Filipiak A., Kowalik J., Mastalerz P. and Knypl J.S., Acta Biochim. Polonica, 32, 131 (1985);
7. (e) Zoń J. and Amrhein M., Liebigs Ann. Chem., 625 (1992);
8. (f) Lejczak B., Kafarski P. and Zygmunt J., Biochemistry, 28, 3549 (1989);
9. (g) Perkins M.N., Stone T.W., Collins J.F. and Curry K., Neurosci. Lett., 23, 333 (1981);
10. (h) Aebischer B., Frey P., Haerter H.P., Herrling P.L. and Müller W., Helv. Chim. Acta, 72, 1043 (1989).
11. (a) Oleksyszyn J., Tyka R. and Mastelerz P., Synthesis, 479 (1978);
12. (b) Kafarski P., Lejczak B. and Szewczyk J., Can. J. Chem., 61, 2425 (1983);
13. (c) Soroka M., Jaworska Z. and Szczȩsny Z., Liebigs. Ann. Chem., 1153 (1990);
14. (d) Kowalik J., Kupczyk-Sobótkowska P. and Mastalerz P., Synthesis, 57 (1981);
15. (e) Oleksyszyn J., Boduszek B., Kam C.M. and Powers J.C., J. Med. Chem., 27, 226 (1994);
16. (f) Hamilton R., Walker B. and Walker B.J., Tetrahedron Lett., 36, 4451 (1995).
17. Umezawa H., Aoyagi T., Suda H., Hamada M. and Takeuchi T., J. Antibiot., 29, 97 (1976).
18. (a) Ezawa K., Minato K. and Dobashi K., Biomed. Pharmacother., 50, 283 (1996);
19. (b) Saiki I., Fuji H., Yoneda J., Abe F., Nakajima N., Tsuruo T. and Azuma I., Int. J. Cancer, 54, 137 (1993);
20. (c) Sekine K., Fuji H. and Abe F., Leukemia, 13, 720 (1999);
21. (d) Sekine K., Fuji H., Abe F. and Hishikawa K., Int. J. Cancer, 94, 485 (2001).
22. Scornik O.A. and Botbol V., Curr. Drug Metabolism, 2, 67, (2001).
23. Melzig M.F. and Borman H., Planta Med., 64, 655, (1998).
24. (a) Draj-Zalesińska M., Wysocka T., Dumańska M., Jagoda E. and Zabel M., Folia Histochemica et Cytobiologica, 40, 125 (2002);
25. (b) Dra̧g-Zalesińska M., Wysocka T., Gȩbarowska E. and Zabel M., Folia Histochemica et Cytobiologica, 37, 133 (1999).
26. Yasuhara S., Zhu Y., Matsui T., Tipirneni N., Yasuhara Y., Kaneki M., Rosenzweig A. and Jeevendra-Martyn J.A., J. Histochem. Cytochem., 51, 873 (2003).
27. Collins A.R., Methods Mol. Biol., 203, 163 (2002).
28. Marcinkowska A., unpublished results.
29. (a) Kanayama N., Kajiwara Y. and Goto J., J. Leukoc. Biol., 57, 129 (1995);
30. (b) Dong X., An B. and Salvucci Kierstead L., J. Immunolog., 164, 129 (2000).
31. (a) Genes into Drugs; Rodney J., Ho Y. and Gibaldi M., Eds.; John Wiley; New York, 171 (2003);
32. (b) Joossens J., Van der Veken P., Lambeir A.-M., Augustyns K. and Haemers A., J. Med. Chem. 47, 2411 (2004).